Ezetimibe
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
67877-490 -
Package NDC
67877-490-01 -
Package NDC
67877-490-05 -
Package NDC
67877-490-30 -
Package NDC
67877-490-55 -
Package NDC
67877-490-90 -
Application number
ANDA209234 -
SPL ID
878751ea-5bea-42ef-8f56-2b15a683c7ae -
SPL set ID
206d702c-b09a-4555-972b-6555d6d6d6e6 -
UNII
EOR26LQQ24 -
RxCUI
349556
What the source publishes
- Labeler
- Ascend Laboratories, LLC
- Active ingredients
- Ezetimibe
- Form
- TABLET
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Ezetimibe",
"splId": "878751ea-5bea-42ef-8f56-2b15a683c7ae",
"labels": [
{
"setId": "206d702c-b09a-4555-972b-6555d6d6d6e6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=206d702c-b09a-4555-972b-6555d6d6d6e6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=206d702c-b09a-4555-972b-6555d6d6d6e6"
}
],
"routes": [
"ORAL"
],
"labeler": "Ascend Laboratories, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 TABLET in 1 BOTTLE (67877-490-01)",
"package_ndc": "67877-490-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20171223"
},
{
"sample": false,
"description": "500 TABLET in 1 BOTTLE (67877-490-05)",
"package_ndc": "67877-490-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20171223"
},
{
"sample": false,
"description": "30 TABLET in 1 BOTTLE (67877-490-30)",
"package_ndc": "67877-490-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20171223"
},
{
"sample": false,
"description": "5000 TABLET in 1 BOTTLE (67877-490-55)",
"package_ndc": "67877-490-55",
"identifierStatus": "well-formed",
"marketing_start_date": "20171223"
},
{
"sample": false,
"description": "90 TABLET in 1 BOTTLE (67877-490-90)",
"package_ndc": "67877-490-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20171223"
}
],
"productId": "67877-490_878751ea-5bea-42ef-8f56-2b15a683c7ae",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "67877-490",
"deaSchedule": null,
"genericName": "Ezetimibe",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "EZETIMIBE",
"strength": "10 mg/1"
}
],
"applicationNumber": "ANDA209234",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20171223",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008553",
"N0000175911"
],
"unii": [
"EOR26LQQ24"
],
"rxcui": [
"349556"
],
"spl_set_id": [
"206d702c-b09a-4555-972b-6555d6d6d6e6"
],
"pharm_class_pe": [
"Decreased Cholesterol Absorption [PE]"
],
"pharm_class_epc": [
"Dietary Cholesterol Absorption Inhibitor [EPC]"
],
"manufacturer_name": [
"Ascend Laboratories, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:67877-490_878751ea-5bea-42ef-8f56-2b15a683c7ae"